Policy & Regulation
Vico Therapeutics' VO659 Phase 1/2a clinical trial reveals new positive interim data in Huntington's disease
16 September 2024 - Netherlands-based clinical-stage genetic medicines company Vico Therapeutics BV announced on Friday that it had revealed new positive interim data in Huntington's disease (HD)...
Roche's OCREVUS ZUNOVO with Halozyme's ENHANZE drug delivery technology receives FDA approval
16 September 2024 - California-based biopharmaceutical company Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced on Friday that Roche (SWX:ROG), a Switzerland-based healthcare company, has received ...
Kine Sciences reports first patient dosed in KINE-101 Phase 1b/2a clinical study
16 September 2024 - South Korea-based clinical-stage biopharmaceutical company Kine Sciences announced on Friday that the first patient has been dosed in its Phase 1b/2a clinical study of KINE-101 for...
GenScript Biotech Corporation names new board members
13 September 2024 - Biotech company that provides life science research application instruments and services GenScript Biotech Corporation (SEHK:1548) announced on Thursday that it has named Dr Ross A...
Johnson & Johnson receives approval from FDA for TREMFYA (guselkumab)
12 September 2024 - Multinational pharmaceutical, biotechnology and medical technologies company Johnson & Johnson (NYSE: JNJ) announced on Wednesday that it has received approval from the US Food...
MedGenome names new chairman
12 September 2024 - Global genomics-driven diagnostics and research services company MedGenome announced on Wednesday that it has named Dr Amit Kakar as the chairman of its board, effective immediatel...